Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Antisense initiates collaborative research program to examine ATL-1101 for prostate cancer

Nov. 14, 2007

Docetaxel/telatinib combination shows promise in cancer patients

Nov. 14, 2007

VioQuest cancer agents progress through early studies

Nov. 14, 2007

AVEO reports positive results from phase I clinical trial of AV-951

Nov. 13, 2007

Synta initiates phase I clinical study of novel Hsp90 inhibitor STA-9090

Nov. 13, 2007

Preclinical studies support investigation of AT-101 in lung cancer

Nov. 13, 2007

Intratumoral TNFerade injection feasible in rectal cancer patients

Nov. 13, 2007

Phase I and II studies of belinostat presented at AACR-NCI-EORTC congress

Nov. 13, 2007

FDA approves IND application for Metastatix's CXCR4 inhibitor MSX-122

Nov. 12, 2007

First patient undergoes StemEx transplant in ExCell registration study

Nov. 12, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....